Organogenesis Holdings Inc.ORGONASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P3
Near historical low
vs 5Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -22.20% |
| Q3 2025 | 27.19% |
| Q2 2025 | -2.30% |
| Q1 2025 | -7.72% |
| Q4 2024 | 11.47% |
| Q3 2024 | -33.64% |
| Q2 2024 | 21.68% |
| Q1 2024 | 8.84% |
| Q4 2023 | 12.42% |
| Q3 2023 | -4.28% |
| Q2 2023 | -2.36% |
| Q1 2023 | -1.69% |
| Q4 2022 | 19.01% |
| Q3 2022 | -6.17% |
| Q2 2022 | 18.84% |
| Q1 2022 | 3.96% |
| Q4 2021 | -7.74% |
| Q3 2021 | 22.31% |
| Q2 2021 | 17.89% |
| Q1 2021 | -1.43% |
| Q4 2020 | 69.83% |
| Q3 2020 | -20.54% |
| Q2 2020 | -13.72% |
| Q1 2020 | 48.63% |
| Q4 2019 | -7.24% |
| Q3 2019 | 1.55% |
| Q2 2019 | 14.62% |
| Q1 2019 | 9.06% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |